Skylight Psychedelics

Psychedelics: They Promote Neural Growth in the Brain, They Have Anti-Addictive Properties and The Effects are Likely Long-Lasting

A recent article by Calder et al. 2022, highlights in detail how classic psychedelics such as psilocybin, LSD and DMT enhance and sustain neuroplasticity and neurogenesis, the growth of new neural connections in the brain. The article analyzes which parts of the brain are most likely to be affected by...

San Francisco De-criminalizes Psychedelics

At its Tuesday meeting (6 September 2022), the San Francisco Board of Supervisors passed a resolution that initiates the decriminalization of psychedelics like psilocybin, the active component of magic mushrooms. The resolution passed unanimously, and also applies to several other psychedelic compounds. The Board of Supervisors calls for the regulation of...

Psychedelic Medicine – A New Era In Mental Health Treatment:

At Skylight Psychedelics, we recognize that the era of psychedelic medicine is here, and with it comes new hope for people struggling with depression, trauma from PTSD, anxiety and addiction. Hobbled for decades by draconian federal regulations, psychedelic medicines like ketamine, psilocybin, MDMA, LSD, DMT, mescaline, ayahuasca and iboga are...